RxDoctor Payments Data

Cyrus Press, MD

Orthopaedic Surgery · Woodbridge, VANPI 1407054208

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (32.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Arthrex at 24.2% of the total. Reporting peaked in 2020 at $6,921 and has fallen 63.7% since, to $2,515 in 2025.

$18,880in general payments, 2019–2025

Across 134 payments — averaging $140.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • Stryker$4K
  • Supreme Orthopedic Systems, LLC$4K
  • Smith+Nephew$3K
  • Shoulder Innovations, Inc.$2K
  • Encore Medical, LP$1K
  • plus $1K from 8 others
$42,364in ownership & investment interests, 2019–2025

Across 6 payments — averaging $7060.70 each. An ownership or investment interest held by the physician or an immediate family member.

  • Lazurite Inc.$42K

What the payments were for

  • Consulting fees$4582%
  • Speaking & faculty fees$2,00011%
  • Travel & lodging$5,68830%
  • Food & beverage$6,17433%
  • Education$4,56024%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,880 in reported general payments places this provider in the 80th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$249,005
Medicare patients
390
Services billed
2,551

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen13$54
Meloxicam12$19

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Woodbridge

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →